RE: Stockgod... Idiots abound at Stockhouse and they seem to inhabit the plays that are about to move.
Having been in this business for a long time, I can tell you that the management would have known (or at least had a great idea) ahead of time that they stood a great chance of approval. In knowing so or suspecting so, they would have had product ready to move NOW, they would have a strong and viable marketing plan NOW, they would have also been in pre-negotiations with retailers to carry it and that with FDA approval can now move ahead. Anyone who has been on a board of directors knows that the company would known the odds befiore the FDA trials and subsequent approvals. Otherwise no funding approval from the board. So lets make it clear here, I am NOT a shareholder (as yet) but will be Monday at any price. I know the millions this will generate in time and even possibly bring a little aquisitor interest.
Not withstanding my ownership of shares, a steady news flow is coming, cash flow is coming (I expect a "Wal-Mart" sized order right away), and an involvement by the large and small denizens of the pharma and investing communities.I also expect exclusive distribution and licensing agreements with Asian, Indo Pacific and European markets.
If none of you have ever seen what a "juggernaut" is and does (latest eample being V.NKL a few months back) then stay tuned for a bit. You heard here first.....right from the horses mouth.